Revvity (RVTY) Cash & Equivalents (2009 - 2026)
Revvity (RVTY) reported Cash & Equivalents of $860.3 million for Q2 2026, down 24.38% on a YoY basis from $1.1 billion in Q2 2025, and down 6.47% quarter-over-quarter from $919.9 million in Q4 2025.
Revvity (RVTY) Cash & Equivalents (2009 - 2026) Analysis & Trends
Revvity has reported Cash & Equivalents for 18 years, with the latest figure at $860.3 million in Q2 2026.
- For the quarter ending Q2 2026, Cash & Equivalents fell 24.38% year-over-year to $860.3 million; the trailing twelve-month figure through Apr 2026 stood at $860.3 million (down 24.38% YoY), and the FY2025 full-year result was $919.9 million, down 20.93% from the prior year.
- Cash & Equivalents for Q2 2026 stood at $860.3 million, down from $919.9 million in the prior quarter.
- The five-year high for Cash & Equivalents was $2.3 billion in Q2 2023, with the low at $345.9 million in Q3 2022.
- Historically, Cash & Equivalents has averaged $977.1 million across 5 years, with a median of $961.6 million in 2025.
- Annual changes were most pronounced in 2023 — Cash & Equivalents jumped 285.1% — and 2024, when it plunged 55.98%.
- Revvity's Cash & Equivalents stood at $400.7 million in 2022, then jumped by 127.87% to $913.2 million in 2023, then advanced by 27.4% to $1.2 billion in 2024, then declined by 20.93% to $919.9 million in 2025, then slipped by 6.47% to $860.3 million in 2026.
- The last three Cash & Equivalents figures came in at $860.3 million (Q2 2026), $919.9 million (Q4 2025), and $931.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | 462.00 Mn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 3.25 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 5.70 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 200.53 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 1.81 Bn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 1.95 Bn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 1.10 Bn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 1.09 Bn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 60.60 Mn |
| 10 | Revvity | 11.23 Bn | 10.37 Bn | 387.66 Mn | 860.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 5, 2026 | 860.32 Mn |
| Dec 28, 2025 | 919.86 Mn |
| Sep 28, 2025 | 931.39 Mn |
| Jun 29, 2025 | 991.85 Mn |
| Mar 30, 2025 | 1.14 Bn |
| Dec 29, 2024 | 1.16 Bn |
| Sep 29, 2024 | 1.23 Bn |
| Jun 30, 2024 | 1.25 Bn |
| Mar 31, 2024 | 998.08 Mn |
| Dec 31, 2023 | 913.16 Mn |
| Oct 1, 2023 | 1.14 Bn |
| Jul 2, 2023 | 1.33 Bn |
| Apr 2, 2023 | 2.27 Bn |
| Jan 1, 2023 | 454.36 Mn |
| Oct 2, 2022 | 400.74 Mn |
| Jul 3, 2022 | 345.86 Mn |
| Apr 3, 2022 | 654.76 Mn |
| Jan 2, 2022 | 603.32 Mn |
| Oct 3, 2021 | 472.37 Mn |
| Jul 4, 2021 | 572.81 Mn |